Observers performed a relative localisation task in which they reported whether the second of two sequentially presented signals occurred to the left or right of the first. Stimuli were detectability-matched auditory, visual, or auditory-visual signals and the goal was to compare changes in performance with eccentricity across modalities. Visual performance was superior to auditory at the midline, but inferior in the periphery, while auditory-visual performance exceeded both at all locations. No such advantage was seen when performance for auditory-only trials was contrasted with trials in which the first stimulus was auditory-visual and the second auditory only.

17Observers performed a relative localisation task in which they reported whether the second 18 of two sequentially presented signals occurred to the left or right of the first. Stimuli were 19 detectability--matched auditory, visual, or auditory--visual signals and the goal was to 20 compare changes in performance with eccentricity across modalities. Visual performance 21 was superior to auditory at the midline, but inferior in the periphery, while auditory--visual 22 performance exceeded both at all locations. No such advantage was seen when 23 performance for auditory--only trials was contrasted with trials in which the first stimulus 24 was auditory--visual and the second auditory only. 25 26 27 28

No abstract

More than 2 million people live with multiple sclerosis worldwide and the prevalence has been increasing over time. Patients living with multiple sclerosis often explore diet and lifestyle interventions as a means of managing their symptoms and reducing reliance on medication; yet, these approaches are rarely discussed with their physicians. Currently, there is a lack of evidence on when to stop disease-modifying therapies (DMT), and recent research showed no statistically significant difference in the time between relapses when comparing participants who stopped DMT to those who did not, especially over the age of 45. This case report presents 2 patients with multiple sclerosis who made an informed decision to stop their DMT medications and have been managing their condition with a whole food plant-based diet and a healthy lifestyle approach. Over the period of 5 to 6 years since stopping the medications, each patient only had 1 multiple sclerosis flare-up to date. In the report, the focus is on the impact of diet on multiple sclerosis. It adds to currently available literature and encourages further research in the field of managing multiple sclerosis with lifestyle interventions.

A significant proportion of cancers could be prevented by adopting healthy lifestyle behaviours. In addition, healthy lifestyle factors can have a positive impact on cancer outcomes and survival. Yet, most physicians, including oncologists, do not dedicate a significant amount of time addressing these factors with their patients, who instead look to mainstream media and other non-medical sources for information. This has led to an increase in the number of ‘influencers’ in the wellness space who can accumulate a large and captive audience. At times, this has caused friction amongst healthcare professionals who feel that ‘influencers’ may overstate the potential benefits. The reality is that most people, physicians and the public alike, fail to recognise the immense power that lifestyle interventions hold. Rather than shy away from addressing these issues, we should be empowering our patients to take back control over their health. Here, we provide a personal perspective on why addressing lifestyle factors within cancer care is so important and that we can indeed work together with ‘influencers’ to amplify the message.